Loading clinical trials...
Loading clinical trials...
A Randomized Controlled Study Comparing the Impact of Prophylactic Versus Deferred Lamivudine on the Delivery of Cytotoxic Chemotherapy in Hepatitis B Surface-antigen Positive Patients With Malignant Solid Tumor
Conditions
Interventions
Lamivudine
Locations
1
China
Queen Elizabeth Hospital
Hong Kong, China
Start Date
September 1, 2004
Completion Date
June 1, 2008
Last Updated
September 5, 2013
NCT00026884
NCT07213804
NCT07169851
NCT07159659
NCT07191730
NCT07481851
Lead Sponsor
Hospital Authority, Hong Kong
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions